By DAVID GELLES
Allergan, the maker of Botox, sought a $10 billion deal for Salix that would not have required shareholder approval, a move intended to derail a takeover effort by Valeant and Pershing Square.
Published: October 2, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1tlInq3
from WordPress http://ift.tt/1oGCqT0
via Hadi Aboukhater
No comments:
Post a Comment